<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02466334</url>
  </required_header>
  <id_info>
    <org_study_id>H-15006836</org_study_id>
    <nct_id>NCT02466334</nct_id>
  </id_info>
  <brief_title>CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients</brief_title>
  <official_title>CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Headache Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danish Headache Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has previously been shown that nitroglycerine induces cluster headache attacks in episodic
      cluster headache patients (ECH patients) in bouts but not in remission phase. Furthermore,
      plasma concentrations of calcitonin gene-related peptide (CGRP) have been shown to be
      significantly higher during, but not before and after, an attack.

      The attack appears around 20-40 min after nitroglycerine infusion with vasodilatation. During
      this latency period preceding the attack, no increase in CGRP plasma concentrations is seen.
      CGRP induces migraine attacks in 65% of migraine patients, and CGRP antagonists as well as
      monoclonal antibodies against CGRP are effective in migraine treatment.

      Based on the above the investigators hypothesize the following:

        1. Provoking ECH patients in bout with CGRP triggers cluster headache attacks

        2. Provoking ECH patients in remission with CGRP does not trigger cluster headache attacks

        3. Provoking chronic cluster headache patients with CGRP triggers cluster headache attacks
           more often than in ECH patients.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in occurence of cluster headache attacks on CGRP day compared to placebo day in all three groups</measure>
    <time_frame>90 min after administration of study drug</time_frame>
    <description>Occurence of experimentally induced cluster headache attack yes/no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC headache on CGRP day compared to placebo day in all three groups</measure>
    <time_frame>90 min after administration of study drug</time_frame>
    <description>Using 90 min headache questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to maximum headache score on CGRP day compared to placebo day in all three</measure>
    <time_frame>90 min after administration of study drug</time_frame>
    <description>Using 90 min headache questionnaire</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Cluster Headache</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.5µg/min IV calcitonin-gene related peptide for 20 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>IV placebo for 20 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcitonin-Gene Related Peptide</intervention_name>
    <description>1,5 µg/min of IV CGRP over 20 mins</description>
    <arm_group_label>Active</arm_group_label>
    <other_name>CGRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>40 ml of normal saline over 20 mins</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fulfillment of IHS criteria for cluster headache either chronic or episodic

          -  Patients in bouts 1-32 attacks per week

          -  Patients in remission minimum of 1 month remission time

          -  fertile women must use safe contraception

        Exclusion Criteria:

          -  All other primary types of headache

          -  headache 8 hours or less before study day begins

          -  pregnant or lactating women

          -  any history or clinical sigs of hyper/hypotension, heart disease, mental disorder,
             substance abuse, or other illness deemed relevant by the medical doctor assessing the
             patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Messoud Ashina, MD, PhD,DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danish Headache Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Danish Headache Center</name>
      <address>
        <city>Copenhagen</city>
        <state>Glostrup</state>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2015</study_first_submitted>
  <study_first_submitted_qc>June 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2015</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Danish Headache Center</investigator_affiliation>
    <investigator_full_name>Song Guo</investigator_full_name>
    <investigator_title>Medical doctor, Ph.d. student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Cluster Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Salmon calcitonin</mesh_term>
    <mesh_term>Calcitonin</mesh_term>
    <mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

